ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

NIAID Advisors Ok Recompetition of Pediatric ACTGs

February 14, 1992

In Brief: NCI Figure Left unchanged By Carter; Pay Raise Puts further Squeeze On Institute Budget

March 4, 1977

Clinical Trials Approved By NCI Last Month Are Listed

January 25, 2002

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

In Brief: Cancer Panel to Meet Sept. 30 In Boston; House Passes Money Bill, With 41.347 Billion For NCI

August 15, 1986

FDA Adopts Final Diagnostics X-Ray Rule Amendment

September 9, 1977